ArticleOncology reports2019

Involvement of the glutamine RF‑amide peptide and its cognate receptor GPR103 in prostate cancer.

Mohamed Ab Kawan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.